COM:ARCABIO
Oruka Therapeutics
- Stock
Last Close
2.50
30/08 20:00
Market Cap
49.90M
Beta: -
Volume Today
290.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 331K - | 696K 110.27% | 579.50K 16.74% | 784.50K 35.38% | 913.50K 16.44% | 426K 53.37% | 324K 23.94% | 1.10M 238.12% | 1.45M 31.90% | 725.50K 49.79% | 348K 52.03% | |
average receivables | ||||||||||||
book value per share | 227.50 - | 90.60 60.18% | 108.96 20.26% | 44.06 59.56% | 17.73 59.76% | 7.84 55.78% | 5.76 26.53% | 9.88 71.48% | 3.67 62.83% | 2.89 21.23% | 0.00 99.91% | |
capex per share | -0.47 - | -0.12 75.01% | -0.03 73.04% | -0.02 24.33% | -0.01 78.27% | -0.01 0.43% | -0.00 41.77% | -0.00 33.24% | -0.00 23.33% | -0.00 95.51% | ||
capex to depreciation | -1.23 - | -1.58 28.65% | -0.58 63.43% | -0.04 93.52% | -0.01 77.53% | -0.18 2,057.58% | -0.04 75.28% | -0.20 354.57% | -0.47 131.29% | -0.02 96.29% | ||
capex to operating cash flow | 0.01 - | 0.00 66.62% | 0.00 48.30% | 0.00 23.32% | 0.00 78.56% | 0.00 182.58% | 0.00 71.71% | 0.00 195.21% | 0.00 6.82% | 0.00 92.00% | ||
capex to revenue | ||||||||||||
cash per share | 244.66 - | 94.36 61.43% | 111.05 17.68% | 42.01 62.17% | 20.28 51.73% | 8.59 57.65% | 6.33 26.30% | 10.42 64.59% | 3.84 63.16% | 2.95 23.25% | 0.00 99.91% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.01 - | 0.01 14.02% | 0.01 6.80% | 0.01 17.09% | ||||||||
debt to equity | 0.01 - | 0.01 14.65% | 0.01 10.46% | 0.01 17.99% | ||||||||
dividend yield | ||||||||||||
earnings yield | -0.48 - | -0.50 3.94% | -0.39 21.33% | -0.64 62.79% | -1.31 106.10% | -1.74 32.17% | -0.73 58.13% | -0.52 29.05% | -0.64 24.78% | -0.27 57.87% | -0.00 99.92% | |
enterprise value | -2.26M - | 4.12M 282.53% | -9.56M 331.83% | 18.44M 292.97% | 5.38M 70.82% | -2.04M 137.87% | -818.75K 59.82% | -29.77M 3,536.50% | -23.08M 22.47% | -8.01M 65.29% | 24.47B 305,477.30% | |
enterprise value over ebitda | 0.33 - | -0.43 230.36% | 0.84 296.35% | -1.14 236.70% | -0.29 74.63% | 0.26 188.53% | 0.15 42.59% | 3.06 1,973.68% | 1.19 60.93% | 0.76 36.70% | -3.35K 443,600.25% | |
ev to operating cash flow | 0.43 - | -0.44 202.61% | 0.91 307.00% | -1.23 235.63% | -0.31 74.97% | 0.25 180.27% | 0.17 31.01% | 3.85 2,160.04% | 1.23 68.08% | 0.73 40.31% | -4.88K 664,694.55% | |
ev to sales | ||||||||||||
free cash flow per share | -77.68 - | -57.93 25.43% | -30.18 47.90% | -29.77 1.34% | -30.15 1.27% | -10.72 64.45% | -3.64 66.08% | -1.64 54.79% | -1.35 17.74% | -0.76 44.00% | -0.00 99.95% | |
free cash flow yield | -0.37 - | -0.48 31.87% | -0.36 25.49% | -0.58 60.97% | -1.24 113.80% | -1.80 45.44% | -0.64 64.71% | -0.41 35.63% | -0.63 53.43% | -0.32 49.20% | -0.00 99.94% | |
graham net net | 222.71 - | 85.82 61.47% | 106.75 24.39% | 37.18 65.17% | 16.67 55.15% | 7.56 54.67% | 5.63 25.52% | 9.59 70.34% | 3.56 62.89% | 2.85 19.98% | 0.00 99.91% | |
graham number | 720.15 - | 348.40 51.62% | 283.37 18.67% | 179.99 36.48% | 112.82 37.32% | 42.64 62.20% | 23.19 45.62% | 21.43 7.57% | 10.69 50.13% | 6.46 39.52% | 0.00 99.93% | |
income quality | 0.76 - | 0.97 27.39% | 0.92 5.19% | 0.91 0.98% | 0.94 3.68% | 1.04 9.98% | 0.88 15.73% | 0.79 9.42% | 0.97 22.40% | 1.10 13.21% | 0.94 14.57% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -1.74K - | -3.23K 86.22% | -2.86K 11.37% | -3.12K - | -1.01K 67.46% | -830.57 18.15% | -1.09K 30.65% | -15.70 - | ||||
interest debt per share | 0.06 - | 0.02 68.43% | 0.01 37.91% | 0.01 - | 0.01 0.43% | 0.01 49.05% | 0.09 1,575.00% | 0.03 68.96% | 0.07 140.59% | 0.00 99.98% | ||
inventory turnover | ||||||||||||
invested capital | 0.01 - | 0.01 14.65% | 0.01 10.46% | 0.01 17.99% | ||||||||
market cap | 14.50M - | 19.48M 34.34% | 29.25M 50.16% | 25.84M 11.64% | 14.08M 45.51% | 4.57M 67.55% | 7.54M 65.07% | 18.89M 150.36% | 29.89M 58.27% | 34.15M 14.25% | 24.51B 71,658.50% | |
net current asset value | 15.42M - | 14.10M 8.59% | 37.41M 165.39% | 19.01M 49.19% | 10.21M 46.30% | 5.98M 41.39% | 7.55M 26.24% | 46.06M 509.74% | 50.54M 9.73% | 41.29M 18.31% | 36.75M 10.99% | |
net debt to ebitda | 2.43 - | 1.59 34.56% | 3.40 114.04% | 0.46 86.49% | 0.47 2.23% | 0.83 77.49% | 1.51 80.82% | 5.00 231.81% | 2.74 45.13% | 3.98 45.14% | 5.10 28.22% | |
net income per share | -101.32 - | -59.55 41.23% | -32.76 44.99% | -32.68 0.23% | -31.91 2.37% | -10.31 67.69% | -4.15 59.75% | -2.07 50.17% | -1.38 33.10% | -0.64 53.56% | -0.00 99.94% | |
operating cash flow per share | -77.21 - | -57.81 25.13% | -30.15 47.85% | -29.75 1.32% | -30.15 1.34% | -10.71 64.46% | -3.63 66.09% | -1.64 54.87% | -1.35 17.72% | -0.76 43.88% | -0.00 99.95% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.41 - | -0.60 47.87% | -0.29 51.85% | -0.67 131.13% | -1.50 123.71% | -1.16 22.29% | -0.64 44.73% | -0.19 69.93% | -0.35 81.32% | -0.21 38.64% | -0.14 34.36% | |
revenue per share | ||||||||||||
roe | -0.45 - | -0.66 47.59% | -0.30 54.26% | -0.74 146.74% | -1.80 142.59% | -1.31 26.93% | -0.72 45.21% | -0.21 70.94% | -0.38 79.99% | -0.22 41.05% | -0.14 35.07% | |
roic | -0.45 - | -0.66 47.63% | -0.30 54.22% | -0.76 151.31% | -1.82 139.75% | -1.34 26.14% | -0.74 44.70% | -0.21 72.20% | -0.37 80.22% | -0.23 37.01% | -0.19 16.68% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 227.50 - | 90.60 60.18% | 108.96 20.26% | 44.06 59.56% | 17.73 59.76% | 7.84 55.78% | 5.76 26.53% | 9.88 71.48% | 3.67 62.83% | 2.89 21.23% | 0.00 99.91% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 15.58M - | 14.74M 5.39% | 38.07M 158.26% | 22.19M 41.70% | 10.28M 53.70% | 6.03M 41.29% | 7.61M 26.16% | 46.52M 511.31% | 51.04M 9.72% | 41.67M 18.36% | 37.02M 11.17% | |
tangible book value per share | 227.50 - | 90.60 60.18% | 108.96 20.26% | 44.06 59.56% | 17.73 59.76% | 7.84 55.78% | 5.76 26.53% | 9.88 71.48% | 3.67 62.83% | 2.89 21.23% | 0.00 99.91% | |
working capital | 15.42M - | 14.10M 8.58% | 37.41M 165.33% | 19.05M 49.08% | 10.23M 46.30% | 5.98M 41.50% | 7.55M 26.24% | 46.47M 515.16% | 50.92M 9.58% | 41.57M 18.37% | 36.95M 11.10% |
All numbers in USD (except ratios and percentages)